TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 4, Pages 1863-1878
Publisher
American Society for Clinical Investigation
Online
2020-03-09
DOI
10.1172/jci126567
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
- (2019) James R. Burke et al. Science Translational Medicine
- Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
- (2018) Massimo Gadina et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinical management of psoriatic arthritis
- (2018) Filip Van den Bosch et al. LANCET
- Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
- (2018) Atul Deodhar et al. LANCET
- From genome-wide associations to candidate causal variants by statistical fine-mapping
- (2018) Daniel J. Schaid et al. NATURE REVIEWS GENETICS
- IL-17 in the immunopathogenesis of spondyloarthritis
- (2018) Leonie S. Taams et al. Nature Reviews Rheumatology
- Enthesitis: A hallmark of psoriatic arthritis
- (2018) Gurjit S. Kaeley et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The psoriasis-protective TYK2 I684S variant impairs IL-12 stimulated pSTAT4 response in skin-homing CD4+ and CD8+ memory T-cells
- (2018) C. Enerbäck et al. Scientific Reports
- γδTCR regulates production of interleukin-27 by neutrophils and attenuates inflammatory arthritis
- (2018) Laura Bouchareychas et al. Scientific Reports
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
- (2018) Ariane Hammitzsch et al. Scientific Reports
- Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
- (2018) Atul Deodhar et al. Arthritis & Rheumatology
- Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis
- (2018) Isabelle Cambré et al. Nature Communications
- Fine-mapping inflammatory bowel disease loci to single-variant resolution
- (2017) Hailiang Huang et al. NATURE
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Enthesitis: from pathophysiology to treatment
- (2017) Georg Schett et al. Nature Reviews Rheumatology
- Pathogenesis of ankylosing spondylitis — recent advances and future directions
- (2017) Vidya Ranganathan et al. Nature Reviews Rheumatology
- How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches
- (2017) Kliment A. Verba et al. TRENDS IN BIOCHEMICAL SCIENCES
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study
- (2016) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
- (2016) Jürgen Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis
- (2016) Katelijne De Wilde et al. ANNALS OF THE RHEUMATIC DISEASES
- Tyrosine kinase 2 is not limiting human antiviral type III interferon responses
- (2016) Sebastian Fuchs et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Defining the functional binding sites of interleukin 12 receptor β1 and interleukin 23 receptor to Janus kinases
- (2016) Doreen M. Floss et al. MOLECULAR BIOLOGY OF THE CELL
- Normalizing the environment recapitulates adult human immune traits in laboratory mice
- (2016) Lalit K. Beura et al. NATURE
- Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
- (2016) David Ellinghaus et al. NATURE GENETICS
- CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis
- (2016) Danay Cibrian et al. NATURE IMMUNOLOGY
- Ankylosing Spondylitis and Axial Spondyloarthritis
- (2016) Joel D. Taurog et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity
- (2016) C. A. Dendrou et al. Science Translational Medicine
- Sexual Dimorphism in the Th17 Signature of Ankylosing Spondylitis
- (2016) Eric Gracey et al. Arthritis & Rheumatology
- Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice
- (2016) Annika Reinhardt et al. Arthritis & Rheumatology
- The 3 major types of innate and adaptive cell-mediated effector immunity
- (2015) Francesco Annunziato et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
- (2015) Alexandra Y. Kreins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis
- (2015) Eva Hainzl et al. JOURNAL OF IMMUNOLOGY
- TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits
- (2015) Dorothée Diogo et al. PLoS One
- Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
- (2015) John Bowes et al. Nature Communications
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
- (2014) G. L. Stritesky et al. JOURNAL OF IMMUNOLOGY
- Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis
- (2014) Melissa G. Works et al. JOURNAL OF IMMUNOLOGY
- Genetic and epigenetic fine mapping of causal autoimmune disease variants
- (2014) Kyle Kai-How Farh et al. NATURE
- Early infant diagnosis of HIV and fast initiation of anti-retroviral therapy in a rural African setting: how well are we doing?
- (2014) Sara-Jane Smith et al. Paediatrics and International Child Health
- Interleukin-23 Mediates the Intestinal Response to Microbial β-1,3-Glucan and the Development of Spondyloarthritis Pathology in SKG Mice
- (2014) Helen Benham et al. Arthritis & Rheumatology
- Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation
- (2013) E. Keil et al. BLOOD
- Phosphodiesterase 4-targeted treatments for autoimmune diseases
- (2013) Neal Kumar et al. BMC Medicine
- Two Rare Disease-Associated Tyk2 Variants Are Catalytically Impaired but Signaling Competent
- (2013) Z. Li et al. JOURNAL OF IMMUNOLOGY
- Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
- (2013) Adrian Cortes et al. NATURE GENETICS
- Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification
- (2012) Walter P Maksymowych et al. ANNALS OF THE RHEUMATIC DISEASES
- β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice
- (2012) Merja Ruutu et al. ARTHRITIS AND RHEUMATISM
- Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22
- (2012) Hartmann Raifer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- TYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo
- (2012) Michaela Prchal-Murphy et al. PLoS One
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice
- (2011) M. Ishizaki et al. INTERNATIONAL IMMUNOLOGY
- Involvement of Tyrosine Kinase-2 in Both the IL-12/Th1 and IL-23/Th17 Axes In Vivo
- (2011) M. Ishizaki et al. JOURNAL OF IMMUNOLOGY
- IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass
- (2011) I. E. Adamopoulos et al. JOURNAL OF IMMUNOLOGY
- The Inducible Costimulator (ICOS) Is Critical for the Development of Human TH17 Cells
- (2010) C. M. Paulos et al. Science Translational Medicine
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis
- (2009) Hui Shen et al. ARTHRITIS AND RHEUMATISM
- Tyrosine Kinase 2 Plays Critical Roles in the Pathogenic CD4 T Cell Responses for the Development of Experimental Autoimmune Encephalomyelitis
- (2009) A. Oyamada et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started